These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6291741)

  • 1. Biological markers and small cell carcinoma of the lung: a clinical evaluation of urinary ribonucleosides.
    Waalkes TP; Abeloff MD; Ettinger DS; Woo KB; Gehrke CW; Kuo KC; Borek E
    Cancer; 1982 Dec; 50(11):2457-64. PubMed ID: 6291741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified ribonucleosides as biological markers for patients with small cell carcinoma of the lung.
    Waalkes TP; Abeloff MD; Ettinger DS; Woo KB; Gehrke CW; Kuo KC; Borek E
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1267-74. PubMed ID: 6299748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
    Woo KB; Waalkes TP; Ahmann DL; Tormey DC; Gehrke CW; Oliverio VT
    Cancer; 1978 May; 41(5):1685-703. PubMed ID: 348295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary pseudouridine as a tumor marker in patients with small cell lung cancer.
    Tamura S; Fujii J; Nakano T; Hada T; Higashino K
    Clin Chim Acta; 1986 Jan; 154(2):125-32. PubMed ID: 3006946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.
    Heldman DA; Grever MR; Miser JS; Trewyn RW
    J Natl Cancer Inst; 1983 Aug; 71(2):269-73. PubMed ID: 6576186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of urinary nucleosides by high-performance liquid chromatography.
    Liebich HM; Di Stefano C; Wixforth A; Schmid HR
    J Chromatogr A; 1997 Feb; 763(1-2):193-7. PubMed ID: 9129323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct clean-up and analysis of ribonucleosides in physiological fluids.
    Schlimme E; Boos KS; Hagemeier E; Kemper K; Meyer U; Hobler H; Schnelle T; Weise M
    J Chromatogr; 1986 Jun; 378(2):349-60. PubMed ID: 3733993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of urinary excretion of modified nucleosides.
    Gehrke CW; Kuo KC; Waalkes TP; Borek E
    Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine.
    Tormey DC; Waalkes TP; Gehrke CW
    J Surg Oncol; 1980; 14(3):267-73. PubMed ID: 7392649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note.
    Niwa T; Takeda N; Yoshizumi H
    Kidney Int; 1998 Jun; 53(6):1801-6. PubMed ID: 9607216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
    Waalkes TP; Gehrke CW; Zumwalt RW; Chang SY; Lakings DB; Tormey DC; Ahmann DL; Moertel CG
    Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of urinary pseudouridine as a tumor marker in lung cancer.
    Lu JY; Lai RS; Liang LL; Wang HC; Lin TI
    J Formos Med Assoc; 1994 Jan; 93(1):25-9. PubMed ID: 7915576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum protein-bound carbohydrates and small cell carcinoma of the lung. Correlations with extent of disease, tumor burden, survival, and clinical response categories.
    Waalkes TP; Abeloff MD; Ettinger DS; Woo KB; Kuo KC; Gehrke CW
    Cancer; 1983 Jul; 52(1):131-9. PubMed ID: 6303552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen for monitoring patients with small cell carcinoma of the lung during treatment.
    Waalkes TP; Abeloff MD; Woo KB; Ettinger DS; Ruddon RW; Aldenderfer P
    Cancer Res; 1980 Dec; 40(12):4420-7. PubMed ID: 6254646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribonucleosides in human milk. Concentration profiles of these minor constituents as a function of the nursing time.
    Schlimme E; Schneehagen K
    Z Naturforsch C J Biosci; 1995; 50(1-2):105-13. PubMed ID: 7702711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary polyamines for evaluating the course of disease for patients with small cell carcinoma of the lung.
    Woo KB; Waalkes TP; Abeloff MD; Lenhard RE; Gehrke CW; Kuo KC
    Cancer; 1983 Nov; 52(9):1684-90. PubMed ID: 6311401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
    Heldman DA; Grever MR; Speicher CE; Trewyn RW
    J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides.
    Tormey DC; Waalkes TP; Ahmann D; Gehrke CW; Zumwatt RW; Snyder J; Hansen H
    Cancer; 1975 Apr; 35(4):1095-100. PubMed ID: 1116102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma CEA levels in small cell lung cancer. Correlation with stage, distribution of metastases, and survival.
    Lokich JJ
    Cancer; 1982 Nov; 50(10):2154-6. PubMed ID: 6290026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential excretion of modified nucleosides in adult acute leukemia.
    Heldman DA; Grever MR; Trewyn RW
    Blood; 1983 Feb; 61(2):291-6. PubMed ID: 6571786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.